La cadena de opciones muestra datos clave de las opciones de acciones de Nukkleus a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Nukkleus..

Nukkleus (NASDAQ:NUKK) Bolsa, Cadena de Opciones

Nukkleus

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALVO

BBGI

BCAX

ELTX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TMCI

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Earnings

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

PRTG

PRZO

PTPI

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

Nukkleus Inc

WIIM

RXRX

Recursion Pharmaceuticals shares are trading higher after the company announced a workforce reduction  and infrastructure streamlining.

<a href="https://x.com/annmarie/status/1932458367781654694?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg" title="https://x.com/annmarie/status/1932458367781654694?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/annmarie/status/1932458367781654694?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

Macro Economic Events

Politics

Global

Economics

General

BloombergTV Chief Political Correspondent Annmarie Hordern Posts On X "Treasury spokesperson says talks are still on-going."

Guggenheim analyst Jonathan Lee reiterates Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Buy and maintains $25 price target.

Price Target

Reiteration

Analyst Ratings

DAVA

Guggenheim Reiterates Buy on Endava, Maintains $25 Price Target

Aduro Clean Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUR#NASDAQ">ADUR</a>) shares are trading lower Tuesday morning as the stock trends across social media platforms. Here&#8217;s what investors <a href="https://www.benzinga.com/pressreleases/25/06/g45857305/aduro-clean-technologies-announces-pricing-of-us-8-million-underwritten-public-offering">need to know</a>.
What To Know: The decline follows the pricing of an underwritten public offering. The offering includes 947,868 common shares, along with accompanying warrants to purchase 473,934 common shares. The combined public offering price per common share and accompanying half warrant is $8.44.
This offering is <a href="https://www.benzinga.com/pressreleases/25/06/g45857305/aduro-clean-technologies-announces-pricing-of-us-8-million-underwritten-public-offering">expected</a> to generate gross proceeds of approximately $8 million for the clean technology company. Each whole warrant included in the offering has an exercise price of $10.13 per share and will expire three years from the date of issuance.
Aduro intends to allocate the net proceeds from this offering to ongoing research and development costs, expenditures related to the construction of its &#8220;Demonstration-Scale&#8221; plant, and for general corporate purposes and working capital. 
Price Action: ADUR stock is down 19.4% to $7.99 Tuesday morning, according to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45841062/rocket-lab-ast-spacemobile-shares-are-surging-monday-whats-fueling-the-move">Rocket Lab, AST SpaceMobile Shares Are Surging Monday: What&#8217;s Fueling The Move?</a>
<h2 class="wp-block-heading">How To Buy ADUR Stock</h2>
By now you're likely curious about how to participate in the market for Aduro Clean Technologies &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Aduro Clean Technologies, which is trading at $7.99 as of publishing time, $100 would buy you 12.52 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ADUR has a 52-week high of $11.97 and a 52-week low of $3.49.
Image: Shutterstock

ADUR

Aduro Clean Technologies (ADUR) Shares Are Diving: What's Going On?

Guggenheim analyst Jonathan Lee reiterates Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Buy and maintains $125 price target.

GLOB

Guggenheim Reiterates Buy on Globant, Maintains $125 Price Target

SEDG

SolarEdge Technologies shares are trading higher after UBS maintained a Neutral rating on the stock and raised its price target from $17 to $20.

QuantaSing Group shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $6.1 to $9.52.

Rocket Lab USA Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) is blasting off, with its <a href="https://www.benzinga.com/quote/RKLB/news">stock price soaring</a> 530.92% in the past year and 35.32% in the last month, hitting $29.64.
As a key player in small satellite launches, Rocket Lab is capitalizing on the feud between<a href="https://www.benzinga.com/topic/donald-trump"> President Donald Trump</a> and SpaceX's <a href="https://www.benzinga.com/topic/elon-musk">Elon Musk</a>, positioning it as a prime alternative for space contracts.
But with technicals flashing hot, can this rocket keep climbing, or is it time for re-entry?
<h2 class="wp-block-heading">RKLB Price Performance: A Stellar Run</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610"><img loading="lazy" decoding="async" width="628" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10101617/Screenshot-2025-06-10-at-7.46.08-PM.png" alt="" class="wp-image-944825" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10101617/Screenshot-2025-06-10-at-7.46.08-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/10101617/Screenshot-2025-06-10-at-7.46.08-PM-300x232.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0610" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
RKLB's stock has been a cosmic winner, up 15.26% year-to-date and 35.32% in the past month alone. Its $13.28 billion market cap reflects investor frenzy, fueled by a 65-launch track record and new defense contracts. 
The Trump-Musk spat, sparked by Musk's tax bill critique and Trump's threat to cut SpaceX's $22- billion government contracts, has sent RKLB surging 8–9% in days, as X posts call it the "#1 beneficiary." Investors see Rocket Lab's Electron and upcoming Neutron rockets as viable alternatives to SpaceX's Falcon 9, especially for Pentagon and NASA missions.
Related: <a href="https://www.benzinga.com/news/space/25/06/45840240/trump-musk-feud-fuels-spacex-rivals-space-stock-countdown">Trump, Musk Feud Fuels SpaceX Rivals: Space Stock Countdown</a>
<h2 class="wp-block-heading">RKLB Technicals: Bullish Signals With Caution</h2>
Rocket Lab's chart is screaming bullish. The stock trades above its eight-day simple moving average (SMA, $27.58), 20-day SMA ($26.53), 50-day SMA ($22.82) and the 200-day SMA ($19.38), all signaling bullish momentum driving the stock.
The Moving Average Convergence Divergence (MACD, 1.59) confirms momentum, with the MACD line above the signal line, suggesting sustained upward pressure. However, the Relative Strength Index (RSI, 62.64) is nearing overbought territory, hinting at slight selling pressure. 
Cantor Fitzgerald's $35 <a href="https://x.com/ConnorJBates_/status/1932422731519185290">price target</a> (18% upside) and Roth Capital's $35 <a href="https://www.tipranks.com/news/the-fly/rocket-lab-price-target-raised-to-35-from-25-at-roth-capital-thefly">align</a> with the bullish sentiment, though a dip to $25 support could offer a safer entry. Additionally, Wall Street chatter warns of volatility if SpaceX's contracts hold firm.
<h2 class="wp-block-heading">Investor's Play</h2>
RKLB's price surge makes it a speculative darling. Technicals scream bullish, but an RSI nearing 70 suggests caution.
Grab dips near $25 for a ride, or wait for a cooler RSI to avoid a stall. Rocket Lab's no SpaceX, but it's got fuel for now.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45826692/trump-musk-feud-may-not-end-anytime-soon-as-president-says-he-has-no-plans-to-speak-to-the-tesla-ceo">Trump-Musk Feud May Not End Anytime Soon As President Says He Has No Plans To Speak To The Tesla CEO</a></li>
</ul>
Photo: Shutterstock

Tech

RKLB

This 'Direct Beneficiary' Of Trump-Musk Feud Rockets 500%+ In 1 Year - More Fuel Left?

Gelteq Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GELS#NASDAQ">GELS</a>) announced Tuesday that it will expand its U.S. footprint through a <a href="https://www.benzinga.com/pressreleases/25/06/g45856697/gelteq-expands-u-s-operations-with-healthy-extracts-inc-as-north-american-fulfillment-partner" target="_blank" rel="noreferrer noopener">logistics partnership</a> with Healthy Extracts Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/HYEX#OTCQB">HYEX</a>). Healthy Extracts will serve as Gelteq's exclusive North American provider for warehousing, shipping, and order fulfillment of its gel-based delivery products.
This move marks a strategic milestone in Gelteq's efforts to broaden the distribution of its pharmaceutical and wellness-focused gel solutions across the U.S. and Canada while tightening cost controls and optimizing delivery pipelines.
Under the agreement, Healthy Extracts will handle product intake, secure storage, real-time inventory tracking, and outbound distribution from its Henderson, Nevada, facility, which is equipped for high-volume order processing.
Also Read: <a href="https://www.benzinga.com/m-a/25/06/45863046/brown-brown-to-acquire-accession-risk-management-group-for-9-83-billion">Brown &amp; Brown To Acquire Accession Risk Management Group For $9.83 Billion</a>
Gelteq CEO Nathan Givoni said the alliance provides a springboard for rapid North American growth, adding that Healthy Extracts' logistics setup will speed delivery and reduce costs. Healthy Extracts President Duke Pitts said the deal should boost margins and support both companies' financial targets.
With product distribution slated to begin in Q3 2025, both companies anticipate significant gains in operational agility. The partnership sets the stage for future product development and entry into broader wellness segments. The integration of logistics and fulfillment under one umbrella is designed to streamline costs while maximizing growth potential.
Highlights of the deal include an exclusive logistics partnership, synchronized inventory systems for better visibility, and cost-efficient shipping methods, all aimed at unlocking higher profit margins and driving scalability.
Related ETFs: SPDR S&amp;P Health Care Equipment ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHE#NYSE">XHE</a>), Global X Health &amp; Wellness ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFIT#NASDAQ">BFIT</a>).
Price Action: GELS shares are trading higher by 44.12% to $2.41 at last check Tuesday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45859861/grocery-wholesaler-united-natural-foods-terminates-supply-agreement-still-sticks-to-annual-outlook" target="_blank" rel="noreferrer noopener">Grocery Wholesaler United Natural Foods Terminates Supply Agreement, Still Sticks To Annual Outlook</a></li>
</ul>
Photo by Mer_Studio via Shutterstock

BFIT

GELS

HYEX

Gelteq Expands US Footprint With Healthy Extracts Logistics Deal, Stock Surges

KeyBanc Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/62eacb8a9bab060001dbd41a/eric-heath">analyst Eric Heath</a> said the observability market reached $29 billion and could continue recording strong growth. 
Application performance monitoring (APM) is the largest subsegment, generating 42% of revenues, followed by infrastructure monitoring, generating 34%. Heath initiated coverage on two stocks:
<ul class="wp-block-list">
<li>Dynatrace Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) with an Overweight rating and price target of $69.</li>
<li>Elastic NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Sector Weight rating on the stock.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Dynatrace: The company, which is a leader in APM, could continue generating high-teens growth, driven by product and go-to-market catalysts, Heath said in the initiation note. In the enterprise segment, Dynatrace is "a strong #2 consolidator" after Datadog Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>), he added.
"Enterprises are still early in their efforts to consolidate observability tools and Dynatrace's improvements on both product (Grail, logs, LLM observability) and GTM (DPS, Splunk displacements, enterprise focus) we believe will accelerate DT's consolidation activity," the analyst wrote.
Elastic NV: Elastic's data and analytics platform can address several use cases, including Search, Observability, and Security (SIEM), Heath said.
The Search market had matured, but GenAI is "driving a resurgence," the analyst said. He added, however, that this is also resulting in greater competition.
While supporting several use cases, Elastic is "not as differentiated in Observability and SIEM," and faces a highly competitive market.
Price Action: Shares of Dynatrace had risen by 0.15% to $54.29&nbsp;at the time of publication on Tuesday, while Elastic's stock had risen by 0.12% to $85.81.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/short-sellers/25/06/45749896/is-datadog-gaining-or-losing-market-support">Is Datadog Gaining or Losing Market Support?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Initiation

DDOG

ESTC

Seeing Is Believing: 2 Stocks To Watch As Observability Market Hits $29B

Management

DYCQ

DT Cloud Acquisition's Shaoke Li Resigns As CEO And Director Of DT Cloud Acquisition, Effective June 10, 2025;  Guojian Chen Appointed As CEO

At Conference, Reuters Reports Morgan Stanley CEO Ted Pick Reportedly Says Stock Buybacks Will Be Opportunistic; Says Inorganic Opportunities May Be Interesting If Supplementary Leverage Ratio Changes; Says We Are Not Entertaining Inorganic Opportunities At This Time

Getting engaged is one of life's most exciting moments — unless your future bride ends up sharing the spotlight with a Bank of America balance transfer.
That's what happened when a young man <a href="https://youtu.be/j5MTGk_AlOs?si=lt2r_ucpTF0cOqFc">called into "The Ramsey Show"</a> to share the "smart" way he bought an $11,000 engagement ring: with a 0% introductory credit card offer. On paper, it looked brilliant. In practice, Dave Ramsey called it what it was: financial fantasy.
"You did a sweet and good thing," Ramsey told him. "A dumb and bad way."
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
The caller explained that he had $25,000 sitting in a high-yield savings account but chose to finance the ring using a 0% interest promo — because, hey, free money, right?
Wrong.
"Write a check today and pay off the card and place scissors across it and cut it up. Tada. That's it."
Ramsey didn't hold back. He mocked the man's mental gymnastics for trying to game the system to earn a little interest on the side.
"Do you know how much money you made in 60 days on this? Enough to buy a biscuit."
And that's being generous. When the caller tried to justify the decision by citing his 4% <a href="https://www.benzinga.com/personal-finance/management/25/06/45753871/man-calls-dave-ramsey-for-guidance-because-he-has-no-savings-despite-earning-200k-annually">interest rate on savings</a>, Ramsey did the math out loud.
"What's 4% of $10,000? That's $400 a year. Divide that by 12… you can't buy a pizza. Not in New York."
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
But the real gut-punch came when Dave took it personal — wedding style.
"You don't want to be putting that ring on her finger and be going, ‘Thank you, Bank of America.' Gross. That makes me… I got a little throw up in my mouth right now."
Why was Ramsey so fired up? Because he knows the trap.
"This is what Bank of America counts on. Once they've got your head in the noose, they pull the rope."
And he's not wrong. While 0% introductory APR offers can sound like a loophole worth exploiting, they come with fine print most people ignore. <a href="https://www.bankrate.com/credit-cards/zero-interest/what-happens-when-my-0-intro-apr-period-ends/">According to Bankrate</a>, those offers typically expire in 15 to 21 months — and after that, the average APR on credit cards can spike to anywhere between 18.99% and 28.49%, depending on the issuer. One late payment can accelerate the switch, and suddenly, your "free" money turns into a high-interest balance with bite.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Even credit experts agree that it's not always worth the risk. <a href="https://www.experian.com/blogs/ask-experian/what-happens-when-your-0-introductory-apr-ends/">Experian notes</a> that while 0% interest promotions can work if you're extremely disciplined, any misstep can lead to big interest charges, and they're often used by banks to bait overconfident spenders into long-term debt.
So, moral of the story? If you're going to propose, do it with love — not a line of credit. As Ramsey puts it, "Do not play with these snakes. They will bite you."
Congratulations on the engagement… now go pay off the ring.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'Gross. I Got A Little Throw Up In My Mouth Now' — Man Tells Dave Ramsey He Bought An $11,000 Engagement Ring With 0% Interest Credit Card

Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) has outperformed the market over the past 10 years by 5.84% on an annualized basis producing an average annual return of 16.92%. Currently, Wheaton Precious Metals has a market capitalization of $39.79 billion. 
Buying $1000 In WPM: If an investor had bought $1000 of WPM stock 10 years ago, it would be worth $4,698.82 today based on a price of $87.68 for WPM at the time of writing.
<h3>Wheaton Precious Metals's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749568512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Wheaton Precious Metals 10 Years Ago Would Be Worth This Much Today

TME stock has given up its prior gain. Tencent Music Entertainment Group shares were trading higher after the company announced it will acquire Ximalaya.

<a href="https://www.theinformation.com/articles/meta-pay-nearly-15-billion-scale-ai-stake-startups-28-year-old-ceo" title="https://www.theinformation.com/articles/meta-pay-nearly-15-billion-scale-ai-stake-startups-28-year-old-ceo">https://www.theinformation.com/articles/meta-pay-nearly-15-billion-scale-ai-stake-startups-28-year-old-ceo</a>

'Meta Has Agreed To Take A 49% Stake In Data Labeling Firm Scale AI For $14.8 Billion' - The Information

An Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) analyst says the company's<a href="https://www.benzinga.com/markets/tech/25/06/45844424/apple-wwdc-2025-ios-26-announced-with-liquid-glass-design-new-apple-intelligence-features-and-more"> WWDC event </a>was disappointing and featured a lack of surprises and new information.
The AAPL Analyst: Needham analyst Laura Martin reiterated a Hold rating on Apple with no price target. The new note comes shortly after Martin <a href="https://www.benzinga.com/analyst-stock-ratings/downgrades/25/06/45774924/apple-stock-too-pricey-analyst-warns-of-rising-competition-tariff-risks-favors-2-tech-giants">downgraded Apple stock</a> from Buy to Hold and withdrew a $225 price target.
Read Also: <a href="https://www.benzinga.com/news/earnings/25/05/45152493/apple-reports-strong-q2-earnings-revenue-beat-eps-beat-installed-base-hits-all-time-high-across-all-segments-100-billion-buyback-and-more">Apple Reports &#8216;Strong&#8217; Q2 Earnings: Revenue Beat, EPS Beat, Installed Base Hits All-Time High Across All Segments, $100 Billion Buyback And More</a>
The Analyst Takeaways: Martin said Apple's WWDC keynote had "no surprises," a factor that could be due to the large number of blogs dedicated to writing about the company.
"Most key AAPL announcements yesterday, during the WWDC keynote, had been widely written about beforehand," Martin said.
The analyst said three things were new to her during the event: live-call real-time translations, call screening with a call-back option, and a video game hub.
"None of these are important upside value drivers, in our view."
Martin said the event also featured items like Liquid Glass, renaming software upgrades, Siri updates, CarPlay enhancements and more that were previously written about.
"It is difficult for AAPL to surprise Wall Street."
On the Siri update front, Martin said these were "late" and "underwhelming."
"As we stated in our AAPL downgrade last week, we believe that AAPL requires an iPhone upgrade cycle for these shares to work."
Martin said nothing from WWDC will cause consumers to rush out and buy new iPhones in the next 12 months.
"We remain on the sidelines."
While Martin has no price target on Apple stock, the analyst said the $170 to $180 per share range would be "a better entry level" for investors.
AAPL Price Action: Apple stock is up 0.9% to $203.30 on Tuesday versus a 52-week trading range of $169.21 to $260.10. Apple stock fell 1.4% on Monday and shares are down 16.8% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45727606/apple-stock-has-near-term-headwinds-significant-long-term-opportunity-analyst-lays-out-bull-bear-cases-for-tech-giant">Apple Stock Has &#8216;Near Term Headwinds, Significant Long-Term Opportunity&#8217;: Analyst Lays Out Bull, Bear Cases For Tech Giant</a></li>
</ul>
Photo: Tada Images on Shutterstock.com

AAPL

Apple Stock Disappoints After WWDC: Analyst Says This Price Is 'Better Entry Level' For Investors

Reuters Reports U.S. Official Says U.S. And China Have Concluded Trade Talks In London

<a href="https://x.com/DropSiteNews/status/1932452147267846652" title="https://x.com/DropSiteNews/status/1932452147267846652">https://x.com/DropSiteNews/status/1932452147267846652</a>

Legal

ABNB

Drop Site Posts On X "BREAKING: Airbnb Facing Criminal Complaints for Profiting From Israeli War Crimes and Stolen Palestinian Homes ..."

<a href="https://www.nytimes.com/2025/06/10/health/fda-drug-approvals-artificial-intelligence.html">https://www.nytimes.com/2025/06/10/health/fda-drug-approvals-artificial-intelligence.html</a>

'F.D.A. Looks to A.I. to Enhance Efficiency'- New York Times

Small Cap

Opinion

Press Releases

How Growing Number of Industries are Leveraging Artificial Intelligence to Create Lucrative Revenue Opportunities

Landmark $8.7 Billion Defense Deal Highlights Israel's Innovation, as Nukkleus Aligns with Growing Air Defense Momentum

Nukkleus Appoints Brigadier General (Ret.) Mark Beesley as Strategic Advisor for Defense Acquisitions

Nukkleus Sees Accelerating Opportunities in Air Defense Thanks to Trump Executive Order to Develop U.S. 'Iron Dome'

Nukkleus Expands Its Focus on the Defense Sector, Strengthens Capital Structure as it takes Initial Steps Toward Star 26 Acquisition

Nukkleus Advisory Board Member Brigadier General (Ret.) Mark Beesley Highlights Rimon's Strategic Role in Trump's 'Golden Dome' Missile Defense Initiative

Market News Alert: After Nukkleus' 1000% Rise, Wall Street Thinks Silynxcom Could be a Potential Multibagger Israeli Defense Tech Stock

Market Alert: Silynxcom's Drone Awareness Technology Positioned for Growth as Governments Allocate Billions to Counter-Drone Programs Following Russia-Ukraine "Drone War" Lessons

Nukkleus Comments on Trump Administration's Further Commitment to Build a "Golden Dome"

Comments

Nukkleus

Nukkleus (NUKK) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL